JAMA Cardiol 5:11821190 Chilton R, Tikkanen I, Cannon CP, Crowe S, Woerle HJ, Broedl UC, Johansen OE (2015) Effects of empagliflozin on blood pressure and markers of arterial stiffness and vascular resistance in patients with type 2 diabetes
After 12 months of GLP-1 therapy with diet and exercise optimization: weight drops to 205 pounds
This rapid absorption means you might feel the benefits sooner, helping restore your energy levels and overall well-being
For a more detailed look at how these two treatments stack up, reading about Retatrutide vs Tirzepatide can provide additional context
A major consideration in the application of GLP-1 RAs to PD is their metabolic impact
Below, we have provided some information to help you learn more about your weight loss options